fda semaglutide warning november 2025 Diabetes advocacy group discourages use of compounded GLP-1 drugs Cash price for popular weight

It is important to consult a healthcare professional for an accurate diagnosis and appropriate management

In the past, patients took one-size-fits-all drugs for obesity and many felt they had to tough out any discomfort to get the results they hoped for

If you have reduced kidney function, protein targets should be determined by your nephrologist, and standard keto protein recommendations may need downward adjustment

Discussion While GLP-1 RAs are powerful anti-obesity medications (AOMs), they do raise some serious concerns most notably, up to 40% of the profound weight loss induced by these agents can be due to loss of lean mass 3,4,5 and prior studies have shown that a significant portion of this lean mass is muscle 33,34,35